日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes

在CAR-T细胞生成过程中,靶向BCL-2的治疗可通过非凋亡性适应性改变增强疗效。

Aboelella, Nada S; Park, Ryan; Tang, Erting; Asby, Nicholas; Ho, Joshua D; Pan, Tony; Wang, Sidney; Xie, Lishi; Kline, Justin P; Riedell, Peter A; Huang, Jun; LaBelle, James L

Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 study

阿贝西诺他(一种组蛋白去乙酰化酶抑制剂)治疗复发或难治性滤泡性淋巴瘤患者:一项多中心、单臂 II 期研究

Gui, Lin; Liu, Haifeng; Wang, Huaqing; Cao, Junning; Li, Yufu; Yu, Yong; Gao, Yuhuan; Li, Zhenling; Shen, Jianzhen; Zhang, Lei; Zhang, Qingyuan; Pan, Hongming; Zheng, Meifang; Ke, Xiaoyan; He, Hesheng; Guo, Shuangshuang; Wang, Yihao; Xu, Xiaohong; Zou, Liqun; Wu, Wentao; Shi, Yuankai

Stilbenoid gaylussacin modulates particulate matter-induced chromatin remodeling in macrophages to suppress chronic obstructive pulmonary disease

芪类化合物盖鲁沙辛通过调节巨噬细胞中颗粒物诱导的染色质重塑来抑制慢性阻塞性肺疾病。

Sim, Jeong Yeon; Ahn, Jee Hwan; Min, Hye-Young; Kwak, Jae-Hwan; Hong, Suckchang; Kim, Dae-Duk; Lee, Ho-Young

Ubiquitination at pericentromeric regions: directing heterochromatin reassembly during cell division

着丝粒周围区域的泛素化:指导细胞分裂过程中异染色质的重组

Chen, Zhenxuan; Kang, Tiebang; Zhou, Liwen

Conductive coordination nanozyme prodrugs precisely trigger pyroptosis, cuproptosis and ferroptosis for in situ cancer vaccination

导电配位纳米酶前药可精确触发细胞焦亡、铜死亡和铁死亡,用于原位癌症疫苗接种。

Wang, Yuqiao; Zhao, Hao; Sun, Ke; Deng, Dan; Liu, Guanyu; Li, Lan; Liu, Tao; Bao, Lin; Xu, Wei; Chen, Chunying

Potent and selective LSD1 inhibitor DC551040 reveals a promising combination therapy for AML with insight into epigenetic dysregulation

强效且选择性的LSD1抑制剂DC551040揭示了一种有前景的AML联合疗法,并有助于深入了解表观遗传失调。

Wang, Jiang; Wang, Hanlin; Du, Runhua; Li, Chunpu; Su, Mingbo; Wang, Shuni; Kan, Weijuan; Liu, Guobin; Zhang, Yu; Hu, Xiaobei; Gao, Feng; Xu, Gaoya; Li, Cong; Zhu, Wei; Ye, Yunfei; Sheng, Li; Shi, Yuqiang; Shao, Yingying; Song, Jiangzhou; Wang, Yuxian; Wang, Bo; Zhou, Yubo; Huang, He; Li, Jia; Liu, Hong

Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications

靶向代谢-表观遗传-免疫轴治疗癌症:分子机制及治疗意义

Wang, Xing; Luo, Xiyuan; Xiao, Ruiling; Liu, Xiaohong; Zhou, Feihan; Jiang, Decheng; Bai, Jialu; Cui, Ming; You, Lei; Zhao, Yupei

Cleaved SREBP-2 C-terminal fragment noncanonically drives interleukin-1 receptor-associated kinase 1-dependent apoptosis

裂解的SREBP-2 C端片段以非经典方式驱动白细胞介素-1受体相关激酶1依赖性细胞凋亡

Yeon, MyeongHoon; Kim, Won-Kyung; Shin, Hyeon-Bin; Lee, Yun-Bin; Rhee, Hyun-Woo; Seo, Young-Kyo

Double-strand break-free epigenetic programming: a safer path for T-cell therapies

双链断裂无损表观遗传编程:T细胞疗法的更安全途径

Deng, Lanxin; Yang, Yujia; El-Osta, Assam

A novel necroptosis pathway: orchestrated by non-canonical STING-ZBP1 signaling

一种新型坏死性凋亡通路:由非经典STING-ZBP1信号通路调控

Zhu, Xiangyu; Liu, Sijia; Zhang, Long